Mobilization with reduced cyclophosphamide for autologous stem cell transplantation is feasible in patients with systemic sclerosis
Ann‐Christin Pecher(Center for Rheumatology), Jörg Henes(University of Tübingen), Katharina Renate Ach(University of Tübingen), Wichard Vogel(University of Tübingen)
Cited by 7
Related Papers
CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
|JAMA|2023|234
Increased Risk for Malignancies in 131 Affected CTLA4 Mutation Carriers
|Frontiers in Immunology|2018|103
Prevalence of autoimmune disease in women with premature ovarian failure
|The European Journal of Contraception & Reproductive Health Care|2019|77
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
|Autoimmunity Reviews|2023|46
Inhibition of effector B cells by ibrutinib in systemic sclerosis
|Arthritis Research & Therapy|2020|42